Wipeout? Yes or no. Can we discuss?

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

StellargalS

lollipop! POP!
7+ Year Member
Joined
Oct 5, 2013
Messages
287
Reaction score
43
I am not considered qualified for such positions. :bucktooth: Still it doesn't seem like a good thing for overall demand. :nailbiting:
Is any one familiar ? Is it old news or a potential new threat to the number of positions?

Pharmacotherapy. 2013 Aug 22. doi: 10.1002/phar.1344. [Epub ahead of print]
Impact of a New Method of Warfarin Management on Patient Satisfaction, Time, and Cost.
Meyer S, Frei CR, Daniels KR, Forcade NA, Bussey M, Bussey-Smith KL, Bussey HI.
Source
College of Pharmacy, The University of Texas, Austin, Texas; The University of Texas Health Science Center, San Antonio, Texas.

Abstract
STUDY OBJECTIVE:
International normalized ratio self-testing with online remote monitoring and management (STORM2 ) is an alternative to anticoagulation clinic management, but the patient's perspective of this method has not been evaluated in the United States; thus we sought to evaluate the impact of STORM2 on patient satisfaction, time, and cost.

DESIGN:
Prospective pre- and postintervention study.​

SETTING:
Freestanding clinical research center.

PATIENTS:
Forty-three patients treated with long-term warfarin therapy and monitored initially in the anticoagulation clinic setting and then with STORM2 , referred from 11 medical practices.

INTERVENTION:
Patients were asked to complete a survey and the Duke Anticoagulation Satisfaction Scale (DASS) before (at baseline) and after at least 3 months of STORM2 (at follow-up).

MEASUREMENTS AND MAIN RESULTS:
Patient satisfaction and time were assessed by survey and the DASS. Costs were measured from the patient's perspective. Overall 90% of responders preferred STORM2 to traditional clinic management. The DASS questions indicated that patients were more satisfied with their anticoagulation treatment and more likely to recommend oral anticoagulation to a friend after experiencing STORM2 . In addition, patients found STORM2 to be less complicated and more convenient than traditional clinic management. For each traditional monthly visit, patients drove 20 miles and expended a total of 1.8 hours; using 55¢/mile for mileage reimbursement and $15/hour for lost wages, the cost for each visit was $38. The total cost for four STORM2 visits per month was $10, for a net savings of $28 per patient per month. A total of 76% of patients were willing to pay additional money to eliminate a monthly clinic visit.

CONCLUSION:
STORM2 is more convenient, less complicated, preferred by patients, and saves patients time and money compared with clinic management.​
 
I think a lot of pharmacy "innovations" are going to bite us in the butt in the long run.

Tech-check-tech
Automation
Mail-order pharmacy
Remote verification
CPOE (yes, even CPOE)

All of the things listed above (and more) are designed to improve efficiency. Some have even been touted as a way to "free up time" for pharmacists to perform "more clinically oriented roles." But if there's one thing we know about healthcare - it's a business. And if there's one thing we know about any business, it always comes down to dollars and cents. Personnel is almost always the highest cost to any organization. So imagine being required by law to employee x number of 6-figure employees per store, hospital pharmacy, etc. If you can find a way to cut back on that expense - maybe go from 10 to 8 FTEs - you'll do it. So yes, while technology may allow fewer pharmacists to do more, it does decrease the number of pharmacists required to operate a pharmacy as we know it today. If it was legally allowable/feasible to replace a pharmacist with a machine, I don't doubt that the bean counters would do it. Technologies like those listed above and also the STORM2 article you posted above only promise to decrease the demand for pharmacists and exacerbate the current issues with saturation.

Yippee!
:boom:
 
I really don't understand pharmacy managed warfarin clinics in the first place. With all the new anti-Xas coming on the market, managing warfarin is not a sustainable business.
 
I agree 100% with the both of you. Thanks for your feedback. 😳

Talk about resting on ones laurels.
I keep hoping something will stir up the "leaders." They presume they have no cause to act as long as their own livelihood is not threatened.
resting_on_laurels.gif
 
Top